Building resilience during the COVID-19 pandemic and beyond
How health care CFOs are navigating with an eye on the future
From immediate financial impact and strategy shifts to a greater focus on consumers and virtual, explore how health care chief financial officers see ways to navigate the challenges of the pandemic while still driving their organizations’ long-term success.
Putting a price on transparency
How providers can win in a transparent market
As consumers increasingly shop for health care services, providers have an opportunity to build trust with their patients and differentiate their organizations by leading the way on pricing transparency.
Loss of health insurance from the pandemic
RWE focus is shifting to R&D, early investments begin to payoff
How can others catch up?
Companies that have invested in mature RWE capabilities are seeing returns; others are behind. Results from Deloitte’s third RWE benchmarking study reveal how companies still building their capabilities can catch up.
Cell and gene therapies
Delivering scientific innovation requires operating model innovation
Potential disruption by cell and gene therapies calls for an overhaul of current operating models, with a focus on organizational structure, business processes, digital capabilities, risk tolerance, and reimbursement.